
Dow, Nasdaq Up Triple Digits as Energy Stocks Surge
Stocks are higher this afternoon, as investors brush off the latest U.S.-Iran war developments
Loading news...

Stocks are higher this afternoon, as investors brush off the latest U.S.-Iran war developments

Medtronic and Kimberly-Clark are Dividend Aristocrats trading well below historical valuations, offering compelling buy-the-dip opportunities. MDT has strong revenue growth, a robust innovation pipeline, and a 3.3% yield, with a forward P/E of 15.4 versus its historical 17.5. KMB is executing on transformation and innovation, with margin gains, a 5.2% yield, and a forward P/E of 13.0, far below its historical 17.7.

Kimberly-Clark Corporation is undergoing major transformation with a JV in Brazil and the $49B Kenvue acquisition. KMB's shift toward premium brands via KVUE increases revenue scale but introduces integration and brand loyalty risks amid consumer trade-down trends. Post-acquisition, leverage will rise to ~2.8x net debt/EBITDA, pausing share buybacks and potentially impacting credit ratings and dividend stability if synergies disappoint.

First Trust Advisors LP raised its stake in shares of Kenvue Inc. (NYSE: KVUE) by 200.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,667,217 shares of the company's stock after buying an additional 1,778,475 shares

CI Investments Inc. decreased its holdings in shares of Kenvue Inc. (NYSE: KVUE) by 98.2% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,485 shares of the company's stock after selling 519,412 shares during the period. CI

Barington Companies Management LLC acquired a new position in shares of Kenvue Inc. (NYSE: KVUE) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 50,000 shares of the company's stock, valued at approximately $812,000. Kenvue makes up about

Tylenol use among pregnant women fell after U.S. President Donald Trump linked autism to the over-the-counter pain relief medicine, according to an analysis of U.S. emergency room prescribing patterns published in the UK medical journal Lancet.

Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Kenvue (KVUE) or Procter & Gamble (PG). But which of these two stocks offers value investors a better bang for their buck right now?

Bahl and Gaynor Inc. trimmed its position in Kenvue Inc. (NYSE: KVUE) by 35.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 108,824 shares of the company's stock after selling 58,886 shares during the quarter. Bahl and Gaynor Inc.'s holdings in

A Texas judge on Thursday rejected Kenvue's bid to dismiss a lawsuit by that state's Attorney General Ken Paxton accusing the company of concealing autism and other risks to children when pregnant women use Tylenol.

Colonial Trust Advisors trimmed its position in shares of Kenvue Inc. (NYSE: KVUE) by 27.3% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 124,079 shares of the company's stock after selling 46,500 shares during the quarter. Colonial Trust Advisors' holdings

After a 35-year career in the finance industry, including two decades as an institutional stockbroker at Bear Stearns, Lehman Brothers, and Morgan Stanley, I developed an institutional perspective on dividend-focused investing.

Stevens Capital Management LP decreased its holdings in Kenvue Inc. (NYSE: KVUE) by 75.3% during the undefined quarter, according to the company in its most recent filing with the SEC. The fund owned 10,485 shares of the company's stock after selling 31,953 shares during the period. Stevens Capital Management LP's holdings in Kenvue

Raiffeisen Bank International AG raised its stake in shares of Kenvue Inc. (NYSE: KVUE) by 75.4% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 62,372 shares of the company's stock after purchasing an additional 26,810 shares during the

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Kenvue Inc. (NYSE: KVUE). In a filing disclosed on February 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Kenvue stock on January 9th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account. Representative Gilbert Ray

On Feb. 18, 2026, investors weighed Kenvue's earnings momentum against looming merger costs and related risks.

KVUE reports solid Q4 results, with margin gains and broad-based global growth, while moving closer to its planned Kimberly-Clark acquisition.

Kenvue Inc (NYSE:KVUE) reported fourth quarter results that topped Wall Street expectations, while the consumer health company also outlined restructuring steps ahead of its planned combination with Kimberly-Clark. For Q4, Kenvue posted adjusted earnings per share of $0.27, beating analyst estimates of $0.22.

Kenvue (NYSE: KVUE) reported fourth-quarter results yesterday that exceeded analyst expectations, with adjusted EPS of $0.27 beating the FactSet estimate of $0.22 by 23%.

Kenvue Inc (NYSE:KVUE) reported fourth quarter results that topped Wall Street expectations, while the consumer health company also outlined restructuring...